Skip to main content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2006 | OriginalPaper | Hoofdstuk

Is nicotinekauwgom verslavend?

Auteur : dr. M.C. Willemsen

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Nicotinell (in de vorm van kauwgom, zuigtablet of een 24-uurs pleister) en Nicorette (kauwgom, sublinguale tablet, inhalator of 16-uurs pleister), zijn nicotine-bevattende middelen die worden gebruikt als hulpmiddel bij het stoppen met roken. Deze middelen voorzien het lichaam van nicotine zodat er minder lichamelijke onthoudingsverschijnselen optreden. Hierdoor kan de patiënt zich beter concentreren op het doorbreken van de psychische afhankelijkheid van sigaretten.
Literatuur
go back to reference West R, Hajek P, Foulds J. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 2000; 149: 198-202. West R, Hajek P, Foulds J. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 2000; 149: 198-202.
go back to reference Hughes JR. Long-term use of nicotine-replacement therapy. In: Henningfield JE, Stitzer ML (eds). New developments in nicotine-delivery systems. New York: Carlton Publishers, 1991: 64-71. Hughes JR. Long-term use of nicotine-replacement therapy. In: Henningfield JE, Stitzer ML (eds). New developments in nicotine-delivery systems. New York: Carlton Publishers, 1991: 64-71.
go back to reference Shiffman S, Hughes JR, Marino ME De, Paty JA, Gitchell JG, Pillitteri JL. Long term use of over-the-counter nicotine gum. Ongepubliceerde studie, gepresenteerd op de 11th world conference on tobacco or health. Chicago: 6-11 augustus 2000. Shiffman S, Hughes JR, Marino ME De, Paty JA, Gitchell JG, Pillitteri JL. Long term use of over-the-counter nicotine gum. Ongepubliceerde studie, gepresenteerd op de 11th world conference on tobacco or health. Chicago: 6-11 augustus 2000.
go back to reference Hughes JR. Dependence on and abuse of nicotine replacement medications: An update. In: Benowitz NL. Nicotine safety and toxicity. New York: Oxford Univ Press, 1998: 147-57. Hughes JR. Dependence on and abuse of nicotine replacement medications: An update. In: Benowitz NL. Nicotine safety and toxicity. New York: Oxford Univ Press, 1998: 147-57.
go back to reference Hurt RD, Offord KP, Lauger GG, et al. Cessation of long-term nicotine gum use: A prospective, randomized trial. Addiction 1995; 90: 407-13. Hurt RD, Offord KP, Lauger GG, et al. Cessation of long-term nicotine gum use: A prospective, randomized trial. Addiction 1995; 90: 407-13.
go back to reference Spyker DA, Alderfer RJ, Goetsch RA, Longmire AW, Kramer ED. Adverse events and prolonged use of nicotine gum and patch. In: Benowitz NL. Nicotine safety and toxicity. New York: Oxford Univ Press, 1998: 167-72. Spyker DA, Alderfer RJ, Goetsch RA, Longmire AW, Kramer ED. Adverse events and prolonged use of nicotine gum and patch. In: Benowitz NL. Nicotine safety and toxicity. New York: Oxford Univ Press, 1998: 167-72.
go back to reference Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine; a review of the pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44: 498-529. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine; a review of the pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44: 498-529.
go back to reference McNabb ME, Ebert RV, McCusker K. Plasma nicotine levels produced by chewing nicotine gum. JAMA 1982; 248: 865-68. McNabb ME, Ebert RV, McCusker K. Plasma nicotine levels produced by chewing nicotine gum. JAMA 1982; 248: 865-68.
go back to reference Schneider NG, Olmstead RE, Franzon MA, Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet 2001; 40: 661-84. Schneider NG, Olmstead RE, Franzon MA, Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet 2001; 40: 661-84.
go back to reference Hughes JR. Risk/benefit of nicotine replacement in smoking cessation. Drug Safety 1993; 8: 49-50. Hughes JR. Risk/benefit of nicotine replacement in smoking cessation. Drug Safety 1993; 8: 49-50.
go back to reference Murray RP, Bailey WC, Daniels K, Bjornson WM, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Chest 1996; 109: 438-45. Murray RP, Bailey WC, Daniels K, Bjornson WM, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Chest 1996; 109: 438-45.
Metagegevens
Titel
Is nicotinekauwgom verslavend?
Auteur
dr. M.C. Willemsen
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_398